Adverse events associated with bimekizumab for moderate-to-severe plaque psoriasis: A retrospective, multicenter, post-hoc analysis
Saved in:
| Main Authors: | Nikki Zangenah, BA, Maria Vazquez-Machado, BS, Nicole Loranger, BS, Soha Elshaboury, RPH, Kimberly Hashemi, MD, Avery H. LaChance, MD, MPH |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | JAAD International |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666328725000239 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-life Experience of Bimekizumab in 27 Obese Patients With Plaque-type Psoriasis: a 24-week Multicenter Retrospective Study
by: Zeno Fratton, et al.
Published: (2025-01-01) -
Bimekizumab as-needed dosing in patients with psoriasis: a case series
by: Carlota Abbad-Jaime De Aragón, et al.
Published: (2025-12-01) -
Effective treatment of recalcitrant palmoplantar psoriasis in a patient with skin of color using bimekizumab
by: Emily G. Tocco, BS, et al.
Published: (2025-09-01) -
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study – IL PSO (Italian Landscape Psoriasis)
by: D. Orsini, et al.
Published: (2024-12-01) -
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study—IL PSO (Italian Landscape PSOriasis)
by: Helena Gioacchini, et al.
Published: (2025-05-01)